Thyrocare grants 100,150 employee stock options at INR 10 exercise price

Thyrocare Technologies Limited's nomination and remuneration committee has approved the grant of 100,150 stock options to eligible employees of the company and its subsidiary. The options were granted on September 23, 2025, at an exercise price of INR 10 per option, under the Thyrocare Employee Stock Option Scheme.

Each option is convertible into one equity share of the company, with a face value of INR 10, subject to adjustments for corporate actions. The options will vest over three years, with one-third vesting at the end of each year, contingent on the employee's continuous employment.

Employees can exercise their vested options within seven years from the vesting date, or another period approved by the committee or the board as per the scheme. This grant is intended to incentivize and retain key talent within the organization.